Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.24B |
| 2 |
Apple
AAPL
|
+$1.14B |
| 3 |
Tesla
TSLA
|
+$1.05B |
| 4 |
Shopify
SHOP
|
+$1B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.13B |
| 2 |
Netflix
NFLX
|
+$1.1B |
| 3 |
NVO
Novo Nordisk
NVO
|
+$1.03B |
| 4 |
Eli Lilly
LLY
|
+$931M |
| 5 |
Trade Desk
TTD
|
+$899M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.77% |
| 2 | Communication Services | 17.54% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 7% |
| 5 | Financials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Veeva Systems
VEEV
$33.5B
| $110M | 0.06% |
369,458
+294,953
| +396% | +$83M |
|
127
Lam Research
LRCX
$369B
| $107M | 0.06% |
796,608
-48,035
| -6% | -$5.09M |
|
128
Gulfport Energy Corp
GPOR
$2.94B
| $106M | 0.06% |
587,870
+22,676
| +4% | +$3.95M |
|
129
AT&T
T
$162B
| $105M | 0.06% |
3,719,270
-71,070
| -2% | -$2.02M |
|
130
Dorman Products
DORM
$3.82B
| $104M | 0.06% |
666,548
-77,852
| -10% | -$11.2M |
|
131
Bank of America
BAC
$438B
| $102M | 0.06% |
1,982,647
-12,217
| -0.6% | -$596K |
|
132
Independence Realty Trust
IRT
$3.95B
| $102M | 0.06% |
6,227,114
-699,340
| -10% | -$12.1M |
|
133
Burlington
BURL
$23.2B
| $102M | 0.06% |
400,305
-37,478
| -9% | -$10.2M |
|
134
Trinity Industries
TRN
$2.5B
| $99.4M | 0.06% |
3,546,036
-185,109
| -5% | -$5.11M |
|
135
Toll Brothers
TOL
$14.1B
| $99.1M | 0.06% |
717,614
+3,796
| +0.5% | +$496K |
|
|
APLS
136
DELISTED
Apellis Pharmaceuticals
APLS
| $98.4M | 0.06% |
4,348,055
+1,686,232
| +63% | +$39.3M |
|
137
Ameris Bancorp
ABCB
$5.92B
| $97.2M | 0.06% |
1,326,294
+549,187
| +71% | +$38.7M |
|
138
Linde
LIN
$222B
| $96.2M | 0.06% |
202,587
-2,373
| -1% | -$1.12M |
|
139
Lincoln National
LNC
$8.82B
| $93.5M | 0.05% |
2,319,323
+1,056,710
| +84% | +$40.9M |
|
140
Lattice Semiconductor
LSCC
$18B
| $93.3M | 0.05% |
+1,272,786
| New | +$77.4M |
|
141
Guardant Health
GH
$21.3B
| $91.9M | 0.05% |
1,471,294
+755,827
| +106% | +$41.1M |
|
142
Rockwell Automation
ROK
$53.5B
| $91.8M | 0.05% |
262,727
+190,034
| +261% | +$65.6M |
|
143
Kontoor Brands
KTB
$4.68B
| $89M | 0.05% |
1,115,238
+211,750
| +23% | +$15.2M |
|
144
TechnipFMC
FTI
$27.1B
| $86.9M | 0.05% |
2,201,912
+503,503
| +30% | +$18.4M |
|
145
Insmed
INSM
$21.3B
| $86.8M | 0.05% |
602,775
-112,831
| -16% | -$13.8M |
|
|
LADR
146
Ladder Capital
LADR
$1.23B
| $86.2M | 0.05% |
7,898,310
+404,782
| +5% | +$4.55M |
|
147
RTX Corp
RTX
$292B
| $85.3M | 0.05% |
509,855
-5,169
| -1% | -$802K |
|
148
Huron Consulting
HURN
$2.39B
| $85.3M | 0.05% |
580,945
-452
| -0.1% | -$61.6K |
|
149
Crinetics Pharmaceuticals
CRNX
$8.87B
| $85.2M | 0.05% |
2,044,734
+57,616
| +3% | +$1.84M |
|
150
Danaher
DHR
$139B
| $84.4M | 0.05% |
425,575
+220,346
| +107% | +$43.8M |
|
Similar funds
Jennison Associates's Q3 2025 Portfolio in Review
As of Q3 2025, Jennison Associates held 667 positions worth $172B, up 1.9% from $169B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Jennison Associates withdrew a net $8.14B in Q3 2025, closing 107 positions and reducing 253 holdings. Its most notable exit was Fair Isaac, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $627M.
- Jennison Associates's largest Q3 2025 buy was Advanced Micro Devices: 3,874,319 shares worth $627M.
- Jennison Associates added most to Oracle in Q3 2025, an estimated $2.24B increase.
- Jennison Associates's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.13B.
- Jennison Associates fully exited Fair Isaac in Q3 2025, selling an estimated $172M.
- Jennison Associates's ten largest holdings make up 47% of its $172B portfolio in Q3 2025.
- Jennison Associates opened 93 new positions and closed 107 in Q3 2025.
- Jennison Associates's portfolio value rose 1.9% quarter-over-quarter to $172B.
Based on Jennison Associates's 13F filing for Q3 2025, filed 30 Oct 2025.